Carsten Østergård Pedersen, Rune Kaagaard Sørensen and Asbjørn Bjerregaard Ebbesen from Grundfos Holding A/S argue that energy efficiency should be prioritised first in heating
Can single-use absorbent hygiene products gain sustainability? The answer is: Yes. Cagda Biasutti & Dr Stefanie Glathe, from Procter & Gamble explain more.
Beatrix Vereijken and Lynn Rochester share how Mobilise-D develops digital technology to measure mobility in daily life to transform clinical research and health.
Professor of Evolutionary Biology Ashleigh S. Griffin discusses harnessing the power of evolutionary process instead of fighting it, particularly regarding bacterial cells and cooperation.
Professor Laura Grenville-Briggs shares her stance on working together to counter the threat of oomycete diseases, focussing on trans-sectoral approaches to support sustainable plant and crop production systems in Europe.
In two previous pieces from the October 2021 and January 2022 issues of Open Access Government, we have elaborated on how to extend the ATTRACT experiment into a sustainable tool for accelerating breakthrough innovation across Europe.
Elin Eriksen Ødegaard, Director & Professor in Early Childhood Pedagogy from Western Norway University of Applied Sciences, lifts the lid on NORCHILD, a unique research school for early childhood education & care.
Here, several academic experts explain what we need to know about removing the blindfold on antimicrobial resistance - by strengthening clinical microbiology laboratories in resource-limited settings.
The trajectory of a human’s life course is by no means determined at birth. Nevertheless, the circumstances a child is born into and events taking place during the early childhood, or even gestation, shape life-course trajectories.
Hernando Lopez-Bertoni, explores the new wave of molecular cancer therapeutics and states the case for learning the mechanisms as a pro, so one can target them as an artist.
Prof Dr Susanne M Bailer, Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, explains the possibilities of an oncolytic virus platform technology.
Dr Stephen Barnhill MD, CEO of Apollon Formularies Plc, examines medical cannabis and the future of cancer treatments across the UK and the European healthcare sectors.
